<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Indoleamine 2,3-dioxygenase 1 (IDO1) is a tryptophan-catabolising enzyme that induces immune tolerance by modulating T-cell responses </plain></SENT>
<SENT sid="1" pm="."><plain><z:mp ids='MP_0002038'>Carcinomas</z:mp> may create an immunosuppressive state via IDO1 expression </plain></SENT>
<SENT sid="2" pm="."><plain>Here we examined a possible contribution of IDO1 on this phenomenon and investigated whether IDO1 has prognostic value in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: IDO1 expression was investigated by quantitative PCR and western blotting in three <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cell lines, in basal state and after interferon (IFN)-γ stimulation </plain></SENT>
<SENT sid="4" pm="."><plain>Semi-quantitative immunohistochemistry was used to evaluate IDO1 expression in 265 pT1-4N0-2Mx-staged <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Results were related to clinical variables and correlated with amounts of CD3(+) and CD8(+) T lymphocytes, which were quantitatively evaluated using image analysis </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: In vitro expression of IDO1 depended on IFN-γ stimulation </plain></SENT>
<SENT sid="7" pm="."><plain>Higher IDO1 expression at the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> invasion front was an independent adverse prognostic factor in pT1-4N1Mx-staged <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>It was associated with overall survival (P=0.001) and with metachronous <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> (P=0.018) </plain></SENT>
<SENT sid="9" pm="."><plain>IDO1 expression was not associated with the presence of CD3(+) or CD8(+) T lymphocytes </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: Higher IDO1 expression at the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> invasion front is involved in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> progression and correlates with impaired clinical outcome, suggesting that IDO1 is an independent prognostic indicator for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>